Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nanomaterials (Basel, Switzerland)|October 15, 2024
Interaction of 6-Thioguanine with Aluminum Metal-Organic Framework Assisted by Mechano-Chemistry, In Vitro Delayed Drug Release, and Time-Dependent Toxicity to Leukemia CellsSheriff Umar, Xavier Welch, Chihurumanya Obichere, et al.
Frontiers in Oncology|May 1, 2024
Dual targeting of glutamine and serine metabolism in acute myeloid leukemiaKanwal M Hameed, Dominique R Bollino, Amol C Shetty, et al.
Future Medicinal Chemistry|May 12, 2017
Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell linesElizabeth Larocque, N Naganna, Xiaochu Ma, et al.
International Journal of Molecular Sciences|December 17, 2024
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid LeukemiaDominique Bollino, Xinrong Ma, Kayla M Tighe, et al.
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
Frontiers in Oncology|December 29, 2022
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycineDominique Bollino, J Preston Claiborne, Kanwal Hameed, et al.
Oral Oncology|June 6, 2022
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinomaZejia Yang, Jipei Liao, Lisa Schumaker, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It ApproachXiaochu Ma, Jie Zhou, Changhao Wang, et al.
Clinical & Experimental Metastasis|February 6, 2020
Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibitionJipei Liao, Zejia Yang, Brandon Carter-Cooper, et al.
Pageof 2